Table 1.

Summary of breast cancer cell line responses to paclitaxel.

Cell line	Receptor Subtype	ATCC catalog number	–log10(EC50)	Paclitaxel status
HCC-1937	HR-HER2-	CRL-2336	5.24	Resistant*
MDA-MB-231	HR-HER2-	HTB-26	5.46	Resistant
MCF-7	HR+HER2-	HTB-22	6.77	Resistant*
MDA-MB-415	HR+HER2-	HTB-128	6.83	Resistant
BT-474	HR+HER2+	HTB-20	7.44	Resistant
MDA-MB-436	HR-HER2-	HTB-130	7.69	Sensitive
BT-549	HR-HER2-	HTB-122	7.99	Sensitive*
HCC-38	HR-HER2-	CRL-2314	8.11	Sensitive*
MDA-MB-361	HR+HER2+	HTB-27	8.15	Sensitive
ZR-751	HR+HER2-	CRL-1500	8.26	Sensitive
HCC-1143	HR-HER2-	CRL-2321	8.56	Sensitive
T-47D	HR+HER2-	HTB-133	8.84	Sensitive*
ZR-7530	HR+HER2+	CRL-1504	9.48	Sensitive

*Indicates that Paclitaxel response matches response in the Daemen et al. paper.